P21waf1/cip1 upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Gareau, Cristina ^a   Fournier, Marie Josée ^a   Filion, Christine ^a   Coudert, Laetitia ^a   Martel, David ^a   Labelle, Yves ^a   Mazroui, Rachid ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLIN DEPENDENT KINASE INHIBITOR 1; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN CUGBP1; UNCLASSIFIED DRUG; BORONIC ACID DERIVATIVE; CELF1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PYRAZINE DERIVATIVE; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DRUG ACTIVITY; GENE SEGREGATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN STABILITY; RNA STABILITY; SIGNAL TRANSDUCTION; UPREGULATION; CELL GRANULE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HELA CELL; METABOLISM; PHYSIOLOGICAL STRESS; PROTEIN SYNTHESIS;

APOPTOSIS; BORONIC ACIDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASMIC GRANULES; DRUG RESISTANCE, NEOPLASM; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PYRAZINES; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 79957547144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020254     Document Type: Article

References (89)

1. Adams J, (2004) The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5 (5): 417-21.
2. Adams J, (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4 (5): 349-60.
3. Drexler HC, (1997) Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci U S A 94 (3): 855-60.
4. Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S, et al. (1995) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem Biophys Res Commun 217 (3): 1070-7.
5. Lopes UG, Erhardt P, Yao R, Cooper GM, (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem 272 (20): 12893-6.
6. Sloss CM, Wang F, Liu R, Xia L, Houston M, et al. (2008) Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells. Clin Cancer Res 14 (16): 5116-23.
7. Richardson PG, Anderson KC, (2003) Bortezomib: a novel therapy approved for multiple myeloma. Clin Adv Hematol Oncol 1 (10): 596-600.
8. Richardson PG, Mitsiades C, Schlossman R, Ghobrial I, Hideshima T, et al. (2008) Bortezomib in the front-line treatment of multiple myeloma. Expert Rev Anticancer Ther 8 (7): 1053-72.
9. Codony-Servat J, Tapia MA, Bosch M, Oliva C, Domingo-Domenech J, et al. (2006) Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. Mol Cancer Ther 5 (3): 665-75.
10. McConkey DJ, Zhu K, (2008) Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 11 (4-5): 164-79.
11. Rajkumar SV, Domingo-Domenech J, Hideshima T, Anderson KC, (2005) Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 23 (3): 630-9.
12. Tang ZY, Wu YL, Gao SL, Shen HW, (2008) Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells. J Surg Res 145 (1): 111-23.
13. Rzymski T, Milani M, Singleton DC, Anderson AL, (2009) Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia. Cell Cycle 8 (23): 3838-47.
14. Fournier MJ, Anderson C, Anderson R, (2010) The chemotherapeutic agent bortezomib induces the formation of stress granules. Cancer Cell Int 10: 12.
15. Moeller BJ, Cao Y, Anderson MW, (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (5): 429-41.
16. Gardner LB, (2008) Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. Mol Cell Biol 28 (11): 3729-41.
17. Mazroui R, Sukarieh R, Bordeleau ME, Kaufman RJ, Northcote P, et al. (2006) Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol Biol Cell 17 (10): 4212-9.
18. McInerney GM, Kedersha NL, Kaufman RJ, Anderson P, Anderson P, (2005) Importance of eIF2alpha phosphorylation and stress granule assembly in alphavirus translation regulation. Mol Biol Cell 16 (8): 3753-63.
19. Kwon S, Zhang Y, Matthias P, (2007) The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev 21 (24): 3381-94.
20. Mazroui R, Di Marco S, Kaufman RJ, Gallouzi IE, (2007) Inhibition of the ubiquitin-proteasome system induces stress granule formation. Mol Biol Cell 18 (7): 2603-18.
21. Anderson P, Kedersha N, (2008) Stress granules: the Tao of RNA triage. Trends Biochem Sci 33 (3): 141-50.
22. Anderson P, Kedersha N, (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 10 (6): 430-6.
23. Balagopal V, Parker R, (2009) Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Curr Opin Cell Biol 21 (3): 403-8.
24. Buchan JR, Parker R, (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36 (6): 932-41.
25. Kedersha N, Cho MR, Li W, Yacono PW, Chen S, et al. (2000) Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol 151 (6): 1257-68.
26. Tsai NP, PC Ho, LN Wei, (2008) Regulation of stress granule dynamics by Grb7 and FAK signalling pathway. Embo J 27 (5): 715-26.
27. Anderson P, Kedersha N, (2006) RNA granules. J Cell Biol 172 (6): 803-8.
28. Kedersha N, Chen S, Gilks N, Li W, Miller IJ, et al. (2002) Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol Biol Cell 13 (1): 195-210.
29. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M, (2008) Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol 10 (11): 1324-32.
30. Kim WJ, Back SH, Kim V, Ryu I, Jang SK, (2005) Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol Cell Biol 25 (6): 2450-62.
31. Kim WJ, Kim JH, Jang SK, (2007) Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. Embo J 26 (24): 5020-32.
32. Lian XJ, Gallouzi IE, (2009) Oxidative stress increases the number of stress granules in senescent cells and triggers a rapid decrease in p21waf1/cip1 translation. J Biol Chem 284 (13): 8877-87.
33. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, et al. (2000) Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19 (47): 5338-47.
34. Gartel AL, Radhakrishnan SK, (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65 (10): 3980-5.
35. Gartel AL, Serfas MS, Tyner AL, (1996) p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 213 (2): 138-49.
36. Gartel AL, Tyner AL, (1999) Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246 (2): 280-9.
37. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, et al. (1999) Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. Embo J 18 (5): 1223-34.
38. Baus F, Gire V, Fisher D, Piette J, Dulic V, (2003) Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. Embo J 22 (15): 3992-4002.
39. Charrier-Savournin FB, Chateau M T, Gire V, Sedivy J, Piette J, et al. (2004) p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 15 (9): 3965-76.
40. Gartel AL, Tyner AL, (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1 (8): 639-49.
41. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, et al. (1997) p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14 (8): 929-35.
42. Gorospe M, Wang X, Holbrook NJ, (1998) p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol Cell Biol 18 (3): 1400-7.
43. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, et al. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20 (3): 760-9.
44. Paillard L, Omilli F, Legagneux V, Bassez T, Maniey D, et al. (1998) EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. Embo J 17 (1): 278-87.
45. Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, et al. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 276 (11): 7820-6.
46. Timchenko NA, Iakova P, Cai ZJ, Smith JR, Timchenko LT, (2001) Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 21 (20): 6927-38.
47. Lee JE, Lee JY, Wilusz J, Tian B, Wilusz CJ, (2010) Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5 (6): 11201.
48. Moraes KC, Wilusz CJ, Wilusz J, (2006) CUG-BP binds to RNA substrates and recruits PARN deadenylase. Rna 12 (6): 1084-91.
49. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, et al. (2010) Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30 (16): 3970-80.
50. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, et al. (2008) Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29 (2): 263-70.
51. Webster PJ, Liang L, Berg CA, Lasko P, Macdonald PM, (1997) Translational repressor bruno plays multiple roles in development and is widely conserved. Genes Dev 11 (19): 2510-21.
52. Zhang L, Lee JE, Wilusz J, Wilusz CJ, (2008) The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 283 (33): 22457-63.
53. Philips AV, Timchenko LT, Cooper TA, (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280 (5364): 737-41.
54. Iakova P, Wang GL, Timchenko L, Michalak M, Pereira-Smith OM, et al. (2004) Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. Embo J 23 (2): 406-17.
55. Kress C, Gautier-Courteille C, Osborne HB, Babinet C, Paillard L, (2007) Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol 27 (3): 1146-57.
56. Fujimura K, Kano F, Murata M, (2008) Dual localization of the RNA binding protein CUGBP-1 to stress granule and perinucleolar compartment. Exp Cell Res 314 (3): 543-53.
57. Bence NF, Bennett EJ, Kopito RR, (2005) Application and analysis of the GFPu family of ubiquitin-proteasome system reporters. Methods Enzymol 399: 481-90.
58. Salomons FA, Verhoef LG, Dantuma NP, (2005) Fluorescent reporters for the ubiquitin-proteasome system. Essays Biochem 41: 113-28.
59. Cusack JC Jr, Liu R, Xia L, Chao TH, Pien C, et al. (2001) Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res 61 (9): 3535-40.
60. Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, et al. (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61 (7): 3071-6.
61. Lenz HJ, (2003) Clinical update: proteasome inhibitors in solid tumors. Cancer Treat Rev 29 (Suppl 1): 41-8.
62. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 (4): 805-16.
63. Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, et al. (2007) Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). Embo J 26 (22): 4683-93.
64. Rieder CL, Maiato H, (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7 (5): 637-51.
65. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, et al. (2000) Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19 (10): 1346-53.
66. Zhan J, Easton JB, Huang S, Mishra A, Xiao L, et al. (2007) Negative regulation of ASK1 by p21Cip1 involves a small domain that includes Serine 98 that is phosphorylated by ASK1 in vivo. Mol Cell Biol 27 (9): 3530-41.
67. Mazroui R, Huot ME, Tremblay S, Boilard N, Labelle Y, et al. (2003) Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs. Hum Mol Genet 12 (23): 3087-96.
68. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, et al. (2002) Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 11 (24): 3007-17.
69. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, et al. (2004) Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. Embo J 23 (15): 3092-102.
70. Mazroui R, Di Marco S, Clair E, von Roretz C, Tenenbaum SA, et al. (2008) Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180 (1): 113-27.
71. Lazzarini R, Moretti S, Orecchia S, Betta PG, Procopio A, et al. (2008) Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma. Clin Cancer Res 14 (16): 5099-107.
72. Crescenzi E, Palumbo G, de Boer J, Brady HJ, (2008) Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. Clin Cancer Res 14 (6): 1877-87.
73. Ferrandiz N, Caraballo JM, Albajar M, Gomez-Casares MT, Lopez-Jorge CE, et al. (2010) p21(Cip1) confers resistance to imatinib in human chronic myeloid leukemia cells. Cancer Lett 292 (1): 133-9.
74. Suzuki A, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, et al. (2000) Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ 7 (8): 721-8.
75. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, et al. (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3 (3): 245-52.
76. Suzuki A, Tsutomi Y, Yamamoto N, Shibutani T, K Akahane, (1999) Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol Cell Biol 19 (5): 3842-7.
77. Suzuki A, Tsutomi Y, Akahane K, Araki T, Akahane M, (1998) Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17 (8): 931-9.
78. Suzuki A, Tsutomi Y, Miura M, Akahane K, (1999) Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18 (5): 1239-44.
79. Gabai VL, Sherman MY, (2002) Invited review: Interplay between molecular chaperones and signaling pathways in survival of heat shock. J Appl Physiol 92 (4): 1743-8.
80. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY, (1998) Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem 273 (11): 6373-9.
81. Seomun Y, Kim JT, Kim HS, Park JY, CK Joo, (2005) Induction of p21Cip1-mediated G2/M arrest in H2O2-treated lens epithelial cells. Mol Vis 11: 764-74.
82. Kedersha N, Anderson P, (2007) Mammalian stress granules and processing bodies. Methods Enzymol 431: 61-81.
83. Mokas S, Mills JR, Garreau C, Fournier MJ, Robert F, et al. (2009) Uncoupling stress granule assembly and translation initiation inhibition. Mol Biol Cell 20 (11): 2673-83.
84. Lin WJ, Duffy A, Chen CY, (2007) Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits. J Biol Chem 282 (27): 19958-68.
85. Salisbury E, Sakai K, Schoser B, Huichalaf C, Schneider-Gold C, et al. (2008) Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp Cell Res 314 (11-12): 2266-78.
86. De Silanes IL, Gorospe M, Taniguchi H, Abdelmohsen K, Srikantan S, et al. (2009) The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA. Nucleic Acids Res 37 (8): 2658-71.
87. Pullmann R Jr, Kim HH, Abdelmohsen K, Lal A, Martindale JL, et al. (2007) Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol Cell Biol 27 (18): 6265-78.
88. Van der Giessen K, Di-Marco S, Clair E, Gallouzi IE, (2003) RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem 278 (47): 47119-28.
89. Graff JR, Konicek BW, Carter JH, Marcusson EG, (2008) Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68 (3): 631-4.